Search Results - "Geiss, Hans C."

Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects by Geiss, Hans C., Otto, Carsten, Schwandt, Peter, Parhofer, Klaus G.

“…Atorvastatin is a potent hydroxy-methyl-glutaryl[ndash ]coenzyme A (HMG-CoA) reductase inhibitor that decreases low-density lipoprotein (LDL) cholesterol and…”
Get full text

Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a) by Ritter, Michael Matthias, Gewitsch, Juri, Richter, Werner O, Geiss, Hans C, Wildner, Manfred W, Schwandt, Peter

“…Previous studies show conflicting results concerning an influence of apolipoprotein E (apo E) phenotype on lipoprotein(a) (Lp(a)) plasma levels. We speculated…”
Get full text

Low Density Lipoprotein Apheresis by Membrane Differential Filtration (Cascade Filtration) by Geiss, Hans C., Parhofer, Donner, Schwandt

“…Membrane differential filtration (MDF) is an apheresis technique with which atherogenic lipoproteins can be eliminated from plasma on the basis of particle…”
Get full text

The Prevention Education Program (PEP). A Prospective Study of the Efficacy of Family-Oriented Life Style Modification in the Reduction of Cardiovascular Risk and Disease: Design and Baseline Data by Schwandt, Peter, Geiß, Hans C., Ritter, Michael M., Üblacker, Christa, Parhofer, Klaus G., Otto, Carsten, Laubach, Ester, Donner, Markus G., Haas, Gerda-M., Richter, Werner O.

“…We describe design and baseline data of the Prevention Education Program (PEP), a home-based and family-oriented intervention program, aimed to assess and…”
Get full text

The Prevention Education Program (PEP). A Prospective Study of the Efficacy of Family-Oriented Life Style Modification in the Reduction of Cardiovascular Risk and Disease by Schwandt, Peter, Geiß, Hans C., Ritter, Michael M., Üblacker, Christa, Parhofer, Klaus G., Otto, Carsten, Laubach, Ester, Donner, Markus G., Haas, Gerda-M., Richter, Werner O.

Get full text

Lipoprotein(a) and Risk of Myocardial Infarction by Ritter, Michael M, Geiss, Hans C, Richter, Werner O, Schwandt, Peter

“…To the Editor.—The article by Ridker et al1 describing similar Lp(a) concentrations in patients with MI and matched controls is very welcome since prospective…”
Get full text

Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia by Ritter, M M, Geiss, H C, Richter, W O, Schwandt, P

“…Lipoprotein(a) [Lp(a)] concentrations are known to be stable under various dietary and drug regimens. Little is known about the influence of…”
Get more information